Superseded. This filing was amended. The current version is 0001437749-26-029257. This page remains published as the record of what was originally filed.
Acquisition (code A) of 789 shares at $1.07 per share.
Reporting Person JORDEN DAVID EMERSON · Officer Title CEO/CFO · Transaction Code A
Traded Aug 27, 2026 · Disclosed Aug 28, 2026
Source: SEC Form 4 · 0001437749-26-029236 · filed 2026-08-28 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Nuo Therapeutics, Inc. (AURX)." Disclosed 2026-08-28. https://desqlong.com/cards/0001437749-26-029236-1 (retrieved 2026-09-26).